Wednesday, December 02, 2020 1:22:13 PM
disappointment as reflected in the share price drop but there are prospects for more developments that the patient can bring. Namely FDA approval and EAU (emergency approval use). I'm holding.
NanoLogix, a small, innovative, historically under-capitalized biotechnology company, has developed this technology through funding and research by the CEO and two Directors, with a keen awareness of the importance of this development relative to the current pandemic. The Company has also benefited from the assistance of a small number of long-term shareholders with lasting faith in the Company’s work and potential. Gratitude is expressed to all involved for their contributions. Thanks also to Gwen Acker Wood, IP Attorney, for her superb attention to detail and experience in patent work.
Bret Barnhizer
Nanologix Incorporated
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM